Process View
Any process that decreases the rate, frequency or extent of metanephros development. Metanephros development is the process whose specific outcome is the progression of the metanephros over time, from its formation to the mature structure. The metanephros is an organ that filters the blood and excretes the end products of body metabolism in the form of urine.
In addition to gene-name show these genes:
Click on a gene's description to view its network relationships with genes known to be involved in "negative regulation of metanephros development"
Name | Description | Probability | Func Analog Organism | |
---|---|---|---|---|
LOC100365106 | rCG32755-like | 0.742 | ||
Rnf213 | ring finger protein 213 | 0.313 | ||
Parp14 | poly (ADP-ribose) polymerase family, member 14 | 0.305 | ||
Stat1 | signal transducer and activator of transcription 1 | 0.245 | ||
LOC100362108 | poly (ADP-ribose) polymerase family, member 10 | 0.211 | ||
Eif2ak2 | eukaryotic translation initiation factor 2-alpha kinase 2 | 0.161 | ||
Stat2 | signal transducer and activator of transcription 2 | 0.123 | Rat | |
Socs3 | suppressor of cytokine signaling 3 | 0.112 | ||
Nfkb1 | nuclear factor of kappa light polypeptide gene enhancer in B-cells 1 | 0.107 | ||
Ifi35 | interferon-induced protein 35 | 0.102 | ||
Sp110 | SP110 nuclear body protein | 0.096 | ||
Nek9 | NIMA (never in mitosis gene a)- related kinase 9 | 0.093 | ||
Tnfrsf1a | tumor necrosis factor receptor superfamily, member 1a | 0.089 | ||
Dtx3l | deltex 3-like (Drosophila) | 0.084 | ||
Irf7 | interferon regulatory factor 7 | 0.074 | ||
RT1-S3 | RT1 class Ib, locus S3 | 0.072 | ||
Parp9 | poly (ADP-ribose) polymerase family, member 9 | 0.070 | ||
Gata3 | GATA binding protein 3 | 0.056 | ||
Clic4 | chloride intracellular channel 4 | 0.049 | ||
Igtp | interferon gamma induced GTPase | 0.048 | ||
Bcl2l1 | Bcl2-like 1 | 0.047 | ||
Rara | retinoic acid receptor, alpha | 0.045 | ||
Il6st | interleukin 6 signal transducer | 0.041 | ||
Tfeb | transcription factor EB | 0.039 | ||
Pim1 | pim-1 oncogene | 0.039 | ||
Smad1 | SMAD family member 1 | 0.036 | ||
Slc6a4 | solute carrier family 6 (neurotransmitter transporter, serotonin), member 4 | 0.036 | ||
Lgals3bp | lectin, galactoside-binding, soluble, 3 binding protein | 0.035 | ||
Hoxc4 | homeo box C4 | 0.035 | ||
Csf2rb | colony stimulating factor 2 receptor, beta, low-affinity (granulocyte-macrophage) | 0.034 | ||
Myo1c | myosin IC | 0.032 | ||
Rsad2 | radical S-adenosyl methionine domain containing 2 | 0.032 | ||
Rela | v-rel reticuloendotheliosis viral oncogene homolog A (avian) | 0.031 | ||
Plxnb2 | plexin B2 | 0.031 | ||
Limd1 | LIM domains containing 1 | 0.031 | ||
Klf6 | Kruppel-like factor 6 | 0.030 | ||
Tgfbr3 | transforming growth factor, beta receptor III | 0.030 | ||
Flt1 | FMS-related tyrosine kinase 1 | 0.027 | ||
Skap1 | src kinase associated phosphoprotein 1 | 0.027 | ||
Irf1 | interferon regulatory factor 1 | 0.027 | ||
Irgm | immunity-related GTPase family, M | 0.027 | ||
Pcsk7 | proprotein convertase subtilisin/kexin type 7 | 0.026 | ||
Ace | angiotensin I converting enzyme (peptidyl-dipeptidase A) 1 | 0.026 | ||
Usp18 | ubiquitin specific peptidase 18 | 0.025 | ||
Mef2d | myocyte enhancer factor 2D | 0.025 | ||
RGD1305793 | similar to hypothetical protein FLJ20154 | 0.025 | ||
A2m | alpha-2-macroglobulin | 0.025 | ||
Stk38 | serine/threonine kinase 38 | 0.024 | ||
Ifi27 | interferon, alpha-inducible protein 27 | 0.024 | ||
Mylk2 | myosin light chain kinase 2 | 0.023 | ||
Map3k3 | mitogen activated protein kinase kinase kinase 3 | 0.023 | ||
Tgfbr2 | transforming growth factor, beta receptor II | 0.023 | ||
Hdac7 | histone deacetylase 7 | 0.023 | ||
Ube2l6 | ubiquitin-conjugating enzyme E2L 6 | 0.023 | ||
Irs1 | insulin receptor substrate 1 | 0.023 | ||
Cish | cytokine inducible SH2-containing protein | 0.022 | ||
Klf13 | Kruppel-like factor 13 | 0.022 | ||
Nos3 | nitric oxide synthase 3, endothelial cell | 0.022 | ||
Nr5a1 | nuclear receptor subfamily 5, group A, member 1 | 0.022 | ||
Bmp7 | bone morphogenetic protein 7 | 0.022 | ||
Igf1r | insulin-like growth factor 1 receptor | 0.022 | ||
Sbk1 | SH3-binding domain kinase 1 | 0.021 | ||
Ddx58 | DEAD (Asp-Glu-Ala-Asp) box polypeptide 58 | 0.020 | ||
Flnb | filamin, beta | 0.020 | ||
Fgg | fibrinogen gamma chain | 0.020 | ||
Pdzk1ip1 | PDZK1 interacting protein 1 | 0.020 | ||
Irs3 | insulin receptor substrate 3 | 0.020 | ||
Gna12 | guanine nucleotide binding protein (G protein) alpha 12 | 0.020 | ||
Bcl2l11 | BCL2-like 11 (apoptosis facilitator) | 0.019 | ||
Acap1 | ArfGAP with coiled-coil, ankyrin repeat and PH domains 1 | 0.019 | ||
Actc1 | actin, alpha, cardiac muscle 1 | 0.019 | ||
Rxra | retinoid X receptor alpha | 0.018 | ||
Il1r1 | interleukin 1 receptor, type I | 0.018 | ||
Cd47 | Cd47 molecule | 0.018 | ||
Tcf3 | transcription factor 3 | 0.018 | ||
Ppp1r15a | protein phosphatase 1, regulatory (inhibitor) subunit 15A | 0.018 | ||
Kdm6b | lysine (K)-specific demethylase 6B | 0.017 | ||
Ece1 | endothelin converting enzyme 1 | 0.017 | ||
Epor | erythropoietin receptor | 0.017 | ||
Fga | fibrinogen alpha chain | 0.017 | ||
Ripk1 | receptor (TNFRSF)-interacting serine-threonine kinase 1 | 0.017 | ||
Ptpn1 | protein tyrosine phosphatase, non-receptor type 1 | 0.017 | ||
Bcl2 | B-cell CLL/lymphoma 2 | 0.016 | ||
Mx2 | myxovirus (influenza virus) resistance 2 | 0.016 | ||
Akap13 | A kinase (PRKA) anchor protein 13 | 0.016 | ||
Art2 | ADP-ribosyltransferase 2 | 0.016 | ||
Hoxb7 | homeo box B7 | 0.016 | ||
Cxcl10 | chemokine (C-X-C motif) ligand 10 | 0.016 | ||
Irf9 | interferon regulatory factor 9 | 0.015 | ||
Lhx1 | LIM homeobox 1 | 0.015 | ||
Gja5 | gap junction protein, alpha 5 | 0.015 | ||
Cytl1 | cytokine like 1 | 0.015 | ||
Rps6ka1 | ribosomal protein S6 kinase polypeptide 1 | 0.015 | ||
Ppp1r12a | protein phosphatase 1, regulatory (inhibitor) subunit 12A | 0.015 | ||
Jun | Jun oncogene | 0.015 | ||
Myh9 | myosin, heavy chain 9, non-muscle | 0.015 | ||
Zfp36 | zinc finger protein 36 | 0.014 | ||
Lfng | LFNG O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase | 0.014 | ||
Fat2 | FAT tumor suppressor homolog 2 (Drosophila) | 0.014 | ||
Pou2f2 | POU class 2 homeobox 2 | 0.014 | ||
Tpsb2 | tryptase beta 2 | 0.014 | ||
Il4ra | interleukin 4 receptor, alpha | 0.014 | ||
LOC690000 | similar to CG3740-PA | 0.014 | ||
Arnt | aryl hydrocarbon receptor nuclear translocator | 0.014 | ||
Clcnkb | chloride channel Kb | 0.014 | ||
Slc39a14 | solute carrier family 39 (zinc transporter), member 14 | 0.013 | ||
Tpsab1 | tryptase alpha/beta 1 | 0.013 | ||
Pdgfrb | platelet derived growth factor receptor, beta polypeptide | 0.013 | ||
Testin | testin gene | 0.013 | ||
Fgr | Gardner-Rasheed feline sarcoma viral (v-fgr) oncogene homolog | 0.013 | ||
Amelx | amelogenin X chromosome | 0.013 | ||
Hyal2 | hyaluronoglucosaminidase 2 | 0.013 | ||
Gabrr2 | gamma-aminobutyric acid (GABA) receptor, rho 2 | 0.013 | ||
Timp3 | TIMP metallopeptidase inhibitor 3 | 0.013 | ||
Ddr1 | discoidin domain receptor tyrosine kinase 1 | 0.013 | ||
Fut4 | fucosyltransferase 4 (alpha (1,3) fucosyltransferase, myeloid-specific) | 0.013 | ||
Scnn1b | sodium channel, nonvoltage-gated 1, beta | 0.013 | ||
LOC619574 | hypothetical protein LOC619574 | 0.013 | ||
Myog | myogenin | 0.013 | ||
Egfl7 | EGF-like-domain, multiple 7 | 0.012 | ||
Sh2d4a | SH2 domain containing 4A | 0.012 | ||
Nr0b2 | nuclear receptor subfamily 0, group B, member 2 | 0.012 | ||
Syde1 | synapse defective 1, Rho GTPase, homolog 1 (C. elegans) | 0.012 | ||
Myo1e | myosin IE | 0.012 | ||
Dnah7 | dynein, axonemal, heavy polypeptide 7 | 0.012 | ||
Cp | ceruloplasmin | 0.012 | ||
Cad | carbamoyl-phosphate synthetase 2, aspartate transcarbamylase, and dihydroorotase | 0.012 | ||
Rarg | retinoic acid receptor, gamma | 0.012 | ||
Kcnq1 | potassium voltage-gated channel, KQT-like subfamily, member 1 | 0.012 | ||
Tln1 | talin 1 | 0.012 | ||
Nr2f2 | nuclear receptor subfamily 2, group F, member 2 | 0.012 | ||
Grin3a | glutamate receptor, ionotropic, N-methyl-D-aspartate 3A | 0.012 | ||
Itgb4 | integrin, beta 4 | 0.012 | ||
Adora2a | adenosine A2a receptor | 0.012 | ||
Nab1 | Ngfi-A binding protein 1 | 0.012 | ||
Eif2c2 | eukaryotic translation initiation factor 2C, 2 | 0.011 | ||
Lgals9 | lectin, galactoside-binding, soluble, 9 | 0.011 | ||
Lama5 | laminin, alpha 5 | 0.011 | ||
Akap1 | A kinase (PRKA) anchor protein 1 | 0.011 | ||
Ung | uracil-DNA glycosylase | 0.011 | ||
Prkch | protein kinase C, eta | 0.011 | ||
Stap2 | signal transducing adaptor family member 2 | 0.011 | ||
Psen1 | presenilin 1 | 0.011 | ||
Amh | anti-Mullerian hormone | 0.011 | ||
Ltbp3 | latent transforming growth factor beta binding protein 3 | 0.011 | ||
RGD735175 | hypothetical protein MGC:72616 | 0.011 | ||
Ttn | titin | 0.011 | ||
Ptpn14 | protein tyrosine phosphatase, non-receptor type 14 | 0.011 | ||
Mov10 | Moloney leukemia virus 10 | 0.011 | ||
Steap2 | six transmembrane epithelial antigen of the prostate 2 | 0.011 | ||
Tor1aip1 | torsin A interacting protein 1 | 0.011 | ||
Gsk3b | glycogen synthase kinase 3 beta | 0.011 | ||
Gns | glucosamine (N-acetyl)-6-sulfatase | 0.011 | ||
Ager | advanced glycosylation end product-specific receptor | 0.011 | ||
Irf2 | interferon regulatory factor 2 | 0.011 | ||
Dcc | deleted in colorectal carcinoma | 0.011 | ||
Bcl3 | B-cell CLL/lymphoma 3 | 0.011 | ||
Creb3l1 | cAMP responsive element binding protein 3-like 1 | 0.011 | ||
Eif4g1 | eukaryotic translation initiation factor 4 gamma, 1 | 0.011 | ||
Agtr2 | angiotensin II receptor, type 2 | 0.010 | ||
Nfic | nuclear factor I/C | 0.010 | ||
Ccdc8 | coiled-coil domain containing 8 | 0.010 | ||
Cryge | crystallin, gamma E | 0.010 | ||
Sardh | sarcosine dehydrogenase | 0.010 | ||
Cast | calpastatin | 0.010 | ||
Aanat | arylalkylamine N-acetyltransferase | 0.010 | ||
Ednra | endothelin receptor type A | 0.010 | ||
Prl3d1 | Prolactin family 3, subfamily d, member 1 | 0.010 | ||
Casp7 | caspase 7 | 0.010 | ||
Cpne3 | copine III | 0.010 | ||
Nfkb2 | nuclear factor of kappa light polypeptide gene enhancer in B-cells 2, p49/p100 | 0.010 | ||
Ceacam11 | carcinoembryonic antigen-related cell adhesion molecule 11 | 0.010 |